Search over 3,000 reports

    Opana ER- Drug Insight, 2017

    Opana ER- Drug Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0367
    "Opana ER - Drug Insight, 2018" report by DelveInsight provides comprehensive information of the drug, Opana ER. It includes Opana ER`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Opana ER`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Opana ER till 2020. The report also throws light on Opana ER`s market competition and emerging therapies in the same space as Opana ER. A SWOT analysis of Opana ER is also featured.
    * Depending on information availability

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
    • Patent information around Opana ER in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Opana ER in United States, Europe, China and India
    • The report contains historical and forecasted sales for Opana ER till 2020
    • Comprehensive coverage of the emerging therapies (Phase III) in the space where Opana ER operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
    • The report also features the SWOT analysis of Opana ER

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Opana ER
    • Access to Opana ER`s API manufacturers details to devise API procurement strategy for generic development
    • Plan developmental timelines around Opana ER`s patents for the major markets- US and EU
    • Understand Opana ER`s current and future growth through its historical and forecasted sales
    • Identify and understand the current in-market competitors for Opana ER
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify and plan ahead for prospective emerging players and their products operating in the same space as Opana ER
    • Identify opportunities in the same area as Opana ER with DelveInsight`s SWOT analysis
    1. Report Introduction
    2. Opana ER - Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Clinical Trials
    • Regulatory Milestones
    • Product Development Activities
    3. Global API Manufacturers
    • United States
    • Europe
    • China
    • India
    4. Product Details
    • United States
    • Europe
    5. Opana ER Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    6. Patent Details
    7. Market Competition
    8. Emerging Therapies
    8.1. Drug name: Company name
    • Product Description
    • Research & Development
    • Product Development Activities
    Other product profiles in the detailed report…..
    9. SWOT Analysis
    Consulting Services
    About DelveInsight
    Contact Us
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Opana ER, Description
    Table 2: API Manufacturers Region wise
    Table 3: API Manufacturers for United States
    Table 4: API Manufacturers for Europe
    Table 5: API Manufacturers for China
    Table 6: API Manufacturers for India
    Table 7: Opana ER Product Details, United States
    Table 8: Opana ER Product Details, Europe
    Table 9: Opana ER, Historical Global Sales till 2017 (in million USD)
    Table 10: Opana ER, Forecasted Global Sales from 2018-2020 (in million USD)
    Table 11: Patent Details: Opana ER
    Table 12: Opana ER Major Competitors
    Table 13: Emerging Therapies
    Figure 1: Opana ER
    Figure 2: Opana ER, Historical Global Sales till 2017 (in million USD)
    Figure 3: Opana ER, Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Opana ER
    Figure 5: API Manufacturers Region wise
    Opana ER

    Opana ER Marketed Drugs Overview

    Opana ER Market Assessment

    Opana ER API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Opana ER US DMF

    Opana ER US Drug Master Files

    Opana ER Active Substance Master File/ EUDMF

    Opana ER Generic players

    Opana ER Patent Expiration

    Opana ER Patent Exclusivity

    Opana ER API Manufacturers

    Opana ER Global Forecasted Sales Figure

    Opana ER API Route of Synthesis

    Opana ER Market sales

    Opana ER SWOT Analysis

    Opana ER Pipeline

    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap